ArticleFrontiers in cellular and infection microbiology2019

Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics.

Kristin R Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.